IMPACT Therapeutics, Inc (HKG:7630)

IMPACT Therapeutics Revenue

IMPACT Therapeutics had revenue of 52.60M CNY in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 118.21M. In the year 2025, IMPACT Therapeutics had annual revenue of 38.25M with 14.02% growth.

• Revenue (ttm): 118.21M CNY
• Revenue Growth: +14.02%
• P/S Ratio: 28.83
• Revenue / Employee: 1.34M CNY
• Employees: 88
• Market Cap: 3.93B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	38.25M	4.70M	14.02%
Dec 31, 2024	33.55M	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 26, 2026

Data Sources Report a data error